Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) Short Interest Update

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) saw a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 469,800 shares, a decline of 43.1% from the January 31st total of 825,200 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is currently 4,698.0 days.

Recordati Industria Chimica e Farmaceutica Price Performance

Shares of RCDTF remained flat at $55.54 during trading hours on Tuesday. Recordati Industria Chimica e Farmaceutica has a twelve month low of $52.25 and a twelve month high of $52.25. The firm has a 50-day moving average price of $55.28 and a 200 day moving average price of $53.30. The company has a market cap of $11.46 billion, a P/E ratio of 27.77 and a beta of 0.30.

About Recordati Industria Chimica e Farmaceutica

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.